Prothena (PRTA) Investor Presentation - Slideshow

Prothena Corporate Overview May 7, 2019 Forward-Looking Statements This overview contains forward-looking statements. These statements relate to, among other things: the strength of our capital position; the potential of our pipeline and the potential to accelerate it and reach significant value inflection points; the design, proposed mechanism of action and possible clinical benefits of prasinezumab (PRX002/RG7935), and its potential as a treatment for Parkinson's disease; the design of the Phase 2 PASADEN ...